Antonio Giordano

The Sbarro Health Research Organization (SHRO) is a non-profit research center founded and led by Dr. Antonio Giordano, a world-renowned oncologist and pathologist. Based at Temple University, the organization focuses on the molecular mechanisms underlying cancer, cardiovascular disease, and diabetes. SHRO is particularly recognized for its pioneering work in cell cycle regulation, including the discovery of the RB2/p130 gene, and its efforts in developing novel diagnostic and therapeutic strategies for mesothelioma and other aggressive cancers. The organization operates as a collaborative hub, bridging academic research with clinical applications through international partnerships and its associated biotech ventures.